QR-Code

Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy

Abstract Introduction A systematic literature review and network meta-analysis (NMA) were conducted to compare the short-term efficacy of lebrikizumab to other biologic and Janus kinase (JAK) inhibitor monotherapies approved for moderate-to-severe atopic dermatitis in adults and adolescents. Methods...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Jonathan I. Silverberg, Thomas Bieber, Amy S. Paller, Lisa Beck, Masahiro Kamata, Luis Puig, Marni Wiseman, Khaled Ezzedine, Alan D. Irvine, Peter Foley, James Del Rosso, Linda Stein Gold, Erin Johansson, Martin Dossenbach, Gaia Gallo, Buelent Akmaz, Marta Casillas, Andrei Karlsson, Tristan Curteis, Raj Chovatiya
Format: Artigo
Sprache:Inglês
Veröffentlicht: Adis, Springer Healthcare 2025-02-01
Schriftenreihe:Dermatology and Therapy
Schlagworte:
Atopic dermatitis
Eczema Area and Severity Index
Investigator Global Assessment
Lebrikizumab
Network meta-analysis
Pruritus/itch Numeric Rating Scale
Online-Zugang:https://doi.org/10.1007/s13555-025-01357-7
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge